Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 12:15PM ET
57.07
Dollar change
-0.12
Percentage change
-0.21
%
IndexS&P 500 P/E17.32 EPS (ttm)3.29 Insider Own1.68% Shs Outstand224.29M Perf Week0.04%
Market Cap12.81B Forward P/E11.39 EPS next Y5.01 Insider Trans-0.25% Shs Float220.78M Perf Month9.92%
Income745.44M PEG0.77 EPS next Q1.07 Inst Own98.02% Short Float4.37% Perf Quarter-5.40%
Sales3.77B P/S3.40 EPS this Y18.27% Inst Trans0.60% Short Ratio4.79 Perf Half Y5.16%
Book/sh24.02 P/B2.38 EPS next Y20.12% ROA11.53% Short Interest9.64M Perf Year-10.22%
Cash/sh17.15 P/C3.33 EPS next 5Y22.50% ROE15.13% 52W Range50.27 - 67.36 Perf YTD-9.11%
Dividend Est.- P/FCF16.21 EPS past 5Y38.99% ROI13.75% 52W High-15.28% Beta0.74
Dividend TTM- Quick Ratio3.43 Sales past 5Y14.55% Gross Margin91.46% 52W Low13.53% ATR (14)1.26
Dividend Ex-Date- Current Ratio3.47 EPS Y/Y TTM127.87% Oper. Margin18.91% RSI (14)63.48 Volatility1.47% 2.29%
Employees2524 Debt/Eq0.01 Sales Y/Y TTM8.58% Profit Margin19.78% Recom1.92 Target Price72.17
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q675.68% Payout0.00% Rel Volume0.55 Prev Close57.19
Sales Surprise-4.45% EPS Surprise-19.46% Sales Q/Q8.93% EarningsApr 30 BMO Avg Volume2.01M Price57.07
SMA205.49% SMA503.26% SMA200-2.43% Trades Volume504,279 Change-0.21%
Date Action Analyst Rating Change Price Target Change
Apr-23-24Initiated Cantor Fitzgerald Neutral
Feb-23-24Initiated Jefferies Buy $81
Feb-14-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-13-23Upgrade Leerink Partners Market Perform → Outperform $78
Dec-04-23Upgrade Guggenheim Neutral → Buy $86
Nov-21-23Downgrade Goldman Buy → Neutral $98 → $65
Jul-25-23Initiated Citigroup Buy $82
May-04-23Downgrade BofA Securities Buy → Neutral $84
Apr-10-23Downgrade RBC Capital Mkts Outperform → Sector Perform $81 → $79
Mar-24-23Upgrade SVB Securities Underperform → Market Perform $61
Today 08:00AM
May-17-24 12:24PM
May-14-24 05:00PM
03:18AM
May-13-24 05:24PM
05:23PM Loading…
05:23PM
01:49PM
12:41PM
10:57AM
09:24AM
09:14AM
08:24AM
07:00AM
May-12-24 08:26AM
May-10-24 03:17PM
06:15AM Loading…
May-09-24 06:15AM
May-02-24 11:17PM
08:00AM
May-01-24 11:24AM
11:12AM
10:53AM
10:33AM
10:20AM
08:55AM
07:58AM
07:50AM
Apr-30-24 04:31PM
02:57PM
11:54AM
11:50AM
10:10AM Loading…
10:10AM
09:36AM
09:30AM
08:34AM
07:10AM
07:00AM
Apr-23-24 10:12AM
10:01AM
09:44AM
07:00AM
Apr-15-24 05:30AM
Apr-11-24 08:00AM
Apr-06-24 08:56AM
Apr-01-24 08:30AM
08:30AM
Mar-31-24 11:53AM
Mar-29-24 04:30PM
Mar-26-24 02:47PM
Mar-17-24 08:50AM
Mar-15-24 10:37AM
Mar-14-24 11:30AM
08:18AM
Mar-12-24 01:52PM
Mar-11-24 01:02PM
07:18AM
Mar-10-24 04:05PM
04:05PM
Mar-07-24 03:00PM
Mar-04-24 08:00AM
Mar-03-24 08:29AM
Feb-29-24 10:19AM
07:30AM
Feb-28-24 01:10PM
Feb-27-24 04:08PM
Feb-26-24 03:20PM
Feb-21-24 04:50PM
Feb-15-24 08:00AM
Feb-14-24 09:32AM
01:15AM
12:12AM
Feb-13-24 05:43PM
11:37AM
09:30AM
08:26AM
08:25AM
07:38AM
07:35AM
07:34AM
07:00AM
Feb-09-24 11:03AM
09:15AM
Feb-07-24 08:55AM
Feb-06-24 04:30AM
Feb-05-24 06:54PM
04:46PM
Jan-31-24 07:33PM
Jan-30-24 11:07AM
Jan-26-24 09:12AM
Jan-24-24 08:39AM
Jan-23-24 08:00AM
Jan-18-24 04:00PM
Jan-08-24 08:30AM
Jan-06-24 11:02AM
Jan-02-24 07:19PM
Dec-20-23 01:50PM
Dec-19-23 11:41AM
Dec-15-23 02:30PM
Dec-12-23 12:46PM
08:00AM
Dec-10-23 05:00PM
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAKER BROS. ADVISORS LPDirectorMay 07 '24Option Exercise49.0130,0001,470,30033,462,981May 09 06:25 PM
Stein Steven HEVP & Chief Medical OfficerJan 03 '24Sale65.517,365482,48190,218Jan 05 12:27 PM
Iyengar Vijay KEVP, GMAPPSJan 02 '24Sale65.0065742,70543,412Jan 04 01:05 PM
Tray ThomasPrincipal Accounting OfficerDec 13 '23Sale62.371,06766,54923,436Dec 14 02:11 PM
Tray ThomasPrincipal Accounting OfficerDec 12 '23Sale57.3621012,04624,503Dec 14 02:11 PM
SWAIN PAULA JEVP, Human ResourcesSep 01 '23Sale65.138,449550,28377,530Sep 06 04:00 PM
Stein Steven HEVP & Chief Medical OfficerAug 01 '23Sale63.2821,5111,361,21697,583Aug 03 04:00 PM